Key Insights

Highlights

Treatment Research

3 treatments under study, led by Centionn

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1

Clinical Trials (1)

Research Network

Common Treatments

  • Centionn1
  • Resinmodified Glass Ionomer1
  • Zirconomer1

Active Sponsors

  • Galal Ali Mohamed Ebaid1

Related Conditions

  • Salivary Ph1
  • Class I Restoration1
  • Primary Molars1
  • Centionn1
  • Resinmodified Glass Ionomer1

Activity Timeline